Found: 10
Select item for more details and to access through your institution.
Modeling hepatitis A epidemiological profiles and estimating the pediatric vaccination threshold in the Russian Federation.
- Published in:
- Frontiers in Public Health, 2024, p. 1, doi. 10.3389/fpubh.2024.1371996
- By:
- Publication type:
- Article
Silent HDV epidemics culminates in high levels of liver cirrhosis in endemic region despite 20 years of HBV vaccination.
- Published in:
- Journal of Viral Hepatitis, 2023, v. 30, n. 3, p. 182, doi. 10.1111/jvh.13783
- By:
- Publication type:
- Article
Post-Vaccination and Post-Infection Immunity to the Hepatitis B Virus and Circulation of Immune-Escape Variants in the Russian Federation 20 Years after the Start of Mass Vaccination.
- Published in:
- Vaccines, 2023, v. 11, n. 2, p. 430, doi. 10.3390/vaccines11020430
- By:
- Publication type:
- Article
Geographic and Temporal Variability of Hepatitis E Virus Circulation in the Russian Federation.
- Published in:
- Viruses (1999-4915), 2023, v. 15, n. 1, p. 37, doi. 10.3390/v15010037
- By:
- Publication type:
- Article
Different evolutionary dynamics of hepatitis B virus genotypes A and D, and hepatitis D virus genotypes 1 and 2 in an endemic area of Yakutia, Russia.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Dynamic Changes in Hepatitis A Immunity in Regions with Different Vaccination Strategies and Different Vaccination Coverage.
- Published in:
- Vaccines, 2022, v. 10, n. 9, p. 1423, doi. 10.3390/vaccines10091423
- By:
- Publication type:
- Article
Different evolutionary dynamics of hepatitis B virus genotypes A and D, and hepatitis D virus genotypes 1 and 2 in an endemic area of Yakutia, Russia.
- Published in:
- BMC Infectious Diseases, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12879-022-07444-w
- By:
- Publication type:
- Article
Avidity of IgG to SARS-CoV-2 RBD as a Prognostic Factor for the Severity of COVID-19 Reinfection.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 3, p. 617, doi. 10.3390/v14030617
- By:
- Publication type:
- Article
Safety and Immunogenicity of the GamTBvac, the Recombinant Subunit Tuberculosis Vaccine Candidate: A Phase II, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study.
- Published in:
- Vaccines, 2020, v. 8, n. 4, p. 652, doi. 10.3390/vaccines8040652
- By:
- Publication type:
- Article
First-In-Human Trials of GamTBvac, a Recombinant Subunit Tuberculosis Vaccine Candidate: Safety and Immunogenicity Assessment.
- Published in:
- Vaccines, 2019, v. 7, n. 4, p. 166, doi. 10.3390/vaccines7040166
- By:
- Publication type:
- Article